Vaccine trials off to fast start for pandemic flu

RSS

USA Today, August 11, 2009

Dozens of adults are enrolled in a flurry of fast-track flu vaccine trials that will grow to include 11,131 adults and 5,740 children, with more trials planned. The vaccine is designed to blunt the effect of a virus that, starting this fall, could infect 100 million people in the United States and cause 30,000 to 90,000 deaths based on scenarios drawn from past pandemics, says Arnold Monto of the University of Michigan, an adviser to the Centers for Disease Control and Prevention and the World Health Organization.

Full Story

Mandatory Flu Shots Gain Traction as the Future of Influenza Prevention

Two large hospital systems have taken on the challenge of implementing a mandatory flu shot policy within the past two years and have seen their compliance rates improve to as high as 98%. Although a mandatory...

Web Exclusive: One Year Later: What Have We Learned from H1N1?

It's been nearly a year since H1N1 arrived in the U.S. How has the healthcare system responded and is the nation any more prepared for a larger health crisis?

Millions of H1N1 Doses Will Expire on Feb. 15

All lots of monovalent 2009 H1N1 influenza vaccine in pre-filled syringes manufactured by Sanofi Pasteur—and not included in two earlier recalls—have a shorter expiration period than indicated on...

Handbook: Medical Executive Committee Essentials Handbook

The Medical Staff Leadership Online Training Library offers a new, easily accessible way for physician leaders to obtain vital medical staff leadership training from the experts at The...

go to complete list